The interplay of the gut microbiome, tryptophan metabolites, and uremic toxin generation in chronic kidney disease progression
Chronic kidney disease (CKD) affects roughly 850 million people worldwide, yet the cardiovascular and immune-related mortality that classical uremic markers cannot fully explain remains the central clinical problem. Much of the small-solute uremic toxin pool is now traceable to gut microbial metabolism, and tryptophan-...